NCT03873311 2022-03-15
Azacytidine + HAG Regimen vs. Azacytidine for Elderly Patients With Newly Diagnosed Myeloid Malignancy
Shenzhen Second People's Hospital
Phase 4 Unknown
Clinical Trials
11 trialsNCT04636918 2020-11-19
Ikervis
Singapore Eye Research Institute
Phase 4 Unknown
NCT02933333 2018-10-17
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4 Unknown
NCT03150134 2017-05-12
Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4 Unknown
NCT03026842 2017-01-20
Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)
The First Hospital of Jilin University
Phase 4 Unknown
NCT02027064 2016-09-29
Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT
Peking University People's Hospital
Phase 4 Unknown
NCT02277847 2014-10-29
Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia
Guangdong Provincial People's Hospital
Phase 4 Unknown
NCT01587430 2014-04-07
3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia
National Research Center for Hematology, Russia
Phase 4 Unknown
NCT02024308 2013-12-31
AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy
Changhai Hospital
Phase 4 Unknown
NCT01806116 2013-03-12
DFMBHSCT
The First Affiliated Hospital of Soochow University
Phase 4 Unknown
NCT00199147 2005-10-26
Efficacy of G-CSF-Priming in Elderly AML Patients
Johann Wolfgang Goethe University Hospital
Phase 4 Unknown